主页 文献库文献详情
PMID: 41639719 已发表 · epublish 英语

The inhibition of the MRN complex by Mirin radiosensitizes particularly HPV-negative HNSCC cell lines.

Cancer cell international ·第 26 卷 ·第 1 期 ·2026-02-04

Hildebrand LS, Mehravani BP, Khalifa M, Schiller P, Langkrär J, Jost T, Fietkau R, Distel LV

摘要

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is a relevant cancer entity with two main risk factors. Human papilloma virus (HPV)-positive ones are induced by virus infection and generally have a good prognosis due to their chemo- and radiosensitivity. In contrast, HPV-negative HNSCCs are primarily caused by tobacco and alcohol abuse; patients have a poor prognosis resulting in the need of innovative targeted and combinatory treatment options. Therefore, we combined the Mre11-Rad50-Nbs1 (MRN) inhibitor Mirin with ionizing radiation (IR). Our hypothesis is that the inhibition of the cancer cells’ DNA damage response (DDR) by Mirin leads to reduced repair capacity and a radiosensitization of the cancer cells. METHODS: We investigated the effect of Mirin in combination with IR on five HPV-negative and two HPV-positive HNSCC cell lines and one primary fibroblast cell line - serving as healthy control - in several functional assays. RESULTS: We suggest – on the one hand - that Mirin shows a trend towards radiosensitizing effects regarding cell death, cell cycle distribution, colony formation, and deoxyribonucleic acid (DNA) damage in HPV-negative HNSCC cell lines but not in HPV-positive ones. On the other hand, the healthy control was nearly unaffected by the combinatory treatment which indicates low side effects. CONCLUSIONS: It is useful to generate a deeper insight into the underlying cellular mechanisms of Mirin response in future studies and further validate Mirin’s potential radiosensitizing effect in HPV-negative HNSCCs.

关键词
DNA damage response Head and neck squamous cell carcinoma Human papilloma virus MRN complex Mirin Radiosensitization Radiotherapy Small molecule inhibitor
文献信息
期刊
Cancer cell international
期刊简称
Cancer Cell Int
ISSN
1475-2867
发表日期
2026-02-04
语言
英语
国家/地区
England
NLM ID
101139795
分析服务
分析服务

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com